Hasan: Nurseries Are To Be Prepared To Reopen In June

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
N05CD08	HIKMA MIDAZOLAM	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	679,984 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	613,662 L.L
J06BA02	PRIVIGEN	BioHuman	Immunoglobulin human - 2.5g/25ml	10%	Injectable solution	23,611,268 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
N05CD08	IPNODIS MEDIS	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	565,758 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	344,754 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	38,549,017 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 2%	2%	Injectable solution	1,787,950 L.L
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	561,726 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
J06BA02	CLAIRYG	BioHuman	Human normal immunoglobulin G - 50mg/ml	5g/100ml	Injectable solution	40,685,649 L.L
N01BB02	LIDOCAINE PANPHARMA 2%	G	Lidocaine (HCl) - 20mg/ml	2%	Injectable solution	3,398,578 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	826,463 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
N01BB02	LIDO-CARE	G	Lidocaine - 2%	2%	Injectable solution	100,788 L.L
B05BC01	OSMITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	28,622,366 L.L
N01BB02	? 2% LIDOCAINE HCL USP	G	Lidocaine HCl - 2%	2%	Injectable solution	255,970 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units		Injectable powder for suspension+diluent	13,873,850 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU		Injectable powder for suspension+diluent	4,102,751 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	36,504,302 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	54,757,132 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L